2003
DOI: 10.1016/s1090-3801(02)00143-x
|View full text |Cite
|
Sign up to set email alerts
|

Recommendations for using opioids in chronic non‐cancer pain

Abstract: 1. The management of chronic pain should be directed by the underlying cause of the pain. Whatever the cause, the primary goal of patient care should be symptom control. 2. Opioid treatment should be considered for both continuous neuropathic and nociceptive pain if other reasonable therapies fail to provide adequate analgesia within a reasonable timeframe. 3. The aim of opioid treatment is to relieve pain and improve the patient's quality of life. Both of these should be assessed during a trial period. 4. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
160
1
15

Year Published

2004
2004
2011
2011

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 223 publications
(179 citation statements)
references
References 25 publications
(31 reference statements)
3
160
1
15
Order By: Relevance
“…Opioids may be useful for neuropathic and nociceptive pain if other strategies fail to provide adequate analgesia within a reasonable time. 4 Opioids are an important treatment option but they must be carefully prescribed and their use managed appropriately.…”
Section: Chronic Pain and Use Of Opioidsmentioning
confidence: 99%
See 1 more Smart Citation
“…Opioids may be useful for neuropathic and nociceptive pain if other strategies fail to provide adequate analgesia within a reasonable time. 4 Opioids are an important treatment option but they must be carefully prescribed and their use managed appropriately.…”
Section: Chronic Pain and Use Of Opioidsmentioning
confidence: 99%
“…Opioids may be useful for neuropathic and nociceptive pain if other strategies fail to provide adequate analgesia within a reasonable time. 4 Opioids are an important treatment option but they must be carefully prescribed and their use managed appropriately.A large meta-analysis of 41 randomised trials involving 6019 patients with nociceptive pain (osteoarthritis, rheumatoid arthritis or back pain), neuropathic pain Prolonged-release oxycodone/ naloxone for chronic pain Naloxone binds selectively to intestinal opioid receptors, without blocking the analgesic effect of oxycodone. …”
mentioning
confidence: 99%
“…transdermal fentanyl, and sustained release oral morphine, should be used. 60,61 Short-acting and injectable opioids may predispose to tolerance and dependence. Effective pain relief should be accompanied by improved physical and psychosocial functioning.…”
Section: Second-line Medicationsmentioning
confidence: 99%
“…Improvements of this kind are possible if use is made of the guidelines published by the WHO, together with the International Narcotics Control Board on achieving balance in a national opioids control policy [103]. At the present time, the WHO is developing a program to assist countries in improving access to medications controlled under the drug conventions [6].…”
mentioning
confidence: 99%